| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President
4 companies
Omstead Daniel R is a President at abrdn Life Sciences Investors with holdings across 4 companies. Recent SEC Form 4 filings include 10 buys and 0 sells.
Estimated insider holdings value: $8.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 25, 2023 | HQL Abrdn Life Sciences Investors | President | Buy | 10,096 | $12.39 | $125,115.69 | +5.4% | +8.9% | +24.3% | |
| Sep 25, 2023 | HQH Abrdn Healthcare Investors | President | Buy | 9,500 | $15.63 | $148,515.40 | +5.6% | +4.7% | +19.9% | |
| Sep 20, 2023 | HQH Abrdn Healthcare Investors | President | Buy | 9,500 | $15.88 | $150,828.65 | +6.0% | +4.0% | +20.4% | |
| Sep 20, 2023 | HQL Abrdn Life Sciences Investors | President | Buy | 12,000 | $12.68 | $152,205.60 | +6.8% | +5.3% | +23.4% | |
| Aug 11, 2021 | HQL Abrdn Life Sciences Investors | President | Buy | 6,403 | $21.63 | $138,496.89 | +4.6% | -1.3% | -19.9% | |
| Oct 26, 2020 | HQH Abrdn Healthcare Investors | President | Buy | 5,200 | $20.53 | $106,744.04 | +4.3% | - | - | |
| Oct 26, 2020 | HQL Abrdn Life Sciences Investors | President | Buy | 6,175 | $17.52 | $108,203.91 | +4.9% | - | - | |
| Oct 21, 2020 | HQH Abrdn Healthcare Investors | President | Buy | 5,050 | $20.68 | $104,427.44 | +4.4% | - | - | |
| Oct 21, 2020 | HQL Abrdn Life Sciences Investors | President | Buy | 5,950 | $17.75 | $105,605.95 | +5.0% | - | - | |
| May 21, 2020 | HQH Abrdn Healthcare Investors | President | Buy | 5,000 | $21.01 | $105,054.00 | +4.7% | - | - |